NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pharmstandard International S.A.

Pharmstandard International S.A.

Luxembourgpharmstd.lu

Overview

Pharmstandard International S.A. is a venture investment company focused on innovative medicines and therapies with strong global potential.

Year Founded

2010

Portfolio Companies

3

Investments

Pharmstandard International S.A. investments
CompanyDateStageLead
OncoTartis, Inc.Dec 2017Series BCo-investor
TearSolutionsDec 2017Series BLead
Avelas BiosciencesAug 2016Series CLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLuxembourg
Year Founded2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.